Prostate Cancer
PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers.
July 1, 2022
Novartis Resumes Production and Delivery of Radioligand Therapy Medicines Ahead of Schedule
June 30, 2022